These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24173182)

  • 21. Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
    Hjalte F; Carlsson KS; Schmitt-Egenolf M
    Br J Dermatol; 2018 Jan; 178(1):245-252. PubMed ID: 28644904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of illness perception on life quality in psoriasis patients.
    Solmaz N; Ilhan N; Bulut HM
    Psychol Health Med; 2021 Sep; 26(8):955-967. PubMed ID: 33191805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to psoriasis treatment in Brazil and Chile: A cross-sectional multicentre Global Healthcare Study on Psoriasis.
    Maul JT; Fröhlich F; Maul LV; Stunnenberg R; Valenzuela F; De La Cruz C; Vera-Kellet C; Armijo D; Cesar WG; Carvalho A; Didaskalu JA; Graf N; Egeberg A; Wu JJ; Thyssen JP; Romiti R; Griffiths CEM
    Br J Dermatol; 2023 Mar; 188(4):533-541. PubMed ID: 36653920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
    Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals.
    Norlin JM; Nilsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2020 Apr; 182(4):965-973. PubMed ID: 31325318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
    Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
    Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life.
    Gerdes S; Körber A; Biermann M; Karnthaler C; Reinhardt M
    J Dermatolog Treat; 2020 Aug; 31(5):470-475. PubMed ID: 32202943
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoriasis has a major secondary impact on the lives of family members and partners.
    Eghlileb AM; Davies EE; Finlay AY
    Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis.
    Puig L; Thom H; Mollon P; Tian H; Ramakrishna GS
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):213-220. PubMed ID: 27739123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of psoriasis on quality of life in Iran.
    Aghaei S; Moradi A; Ardekani GS
    Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of psoriasis severity in Brazilian patients with chronic plaque psoriasis attending outpatient clinics: a multicenter, population-based cross-sectional study (APPISOT).
    Romiti R; Fabrício LHZ; Souza CDS; Galvão LO; de Castro CCS; Terena AC; Carneiro FRO; Oyafuso LKM; Carneiro S; Gontijo B; Kobata CM; de Oliveira MFP; Cestari T; Antônio JR; Martins GA; Marques SA; Chaibub SCW; Arruda ACBB; Félix PAO; Magalhães RF; Abulafia LA; Ferreira KA; Medeiros da Silva A; Silva BL; Souza J
    J Dermatolog Treat; 2018 Dec; 29(8):775-785. PubMed ID: 29697004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment satisfaction, willingness to pay and quality of life in Japanese patients with psoriasis.
    Masaki S; Tatsukawa R; Uryu M; Takahara M; Furue M; Ohata C; Nakama T; Hino R; Nakamura M; Nakayama J; Imafuku S
    J Dermatol; 2017 Feb; 44(2):143-146. PubMed ID: 27599656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation Between Severity Index and Quality of Life Index in Patients With Psoriasis Assessed Before and After Phototherapy.
    Couto MI; Carneiro S; Niemeyer-Corbellini JP; Yoshio JH; Ramos-E-Silva M
    Skinmed; 2016; 14(2):93-7. PubMed ID: 27319951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres.
    Balogh O; Brodszky V; Gulácsi L; Herédi E; Herszényi K; Jókai H; Kárpáti S; Baji P; Remenyik É; Szegedi A; Holló P
    Eur J Health Econ; 2014 May; 15 Suppl 1():S101-9. PubMed ID: 24832841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
    Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
    Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
    Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
    van de Kerkhof PCM; Loewe R; Mrowietz U; Falques M; Pau-Charles I; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):119-126. PubMed ID: 31465585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.